Cargando…

Impact on Tumour Treatment and Outcome of Sars-Cov-2 Infection in 91 Patients with Primary CNS Lymphoma: A Real-Life Study of the International PCNSL Collaborative Group

Detalles Bibliográficos
Autores principales:	Calimeri, Teresa, Steffanoni, Sara, Laurenge, Alice, Fox, Christopher P., Soussain, Carole, Grommes, Christian, Tisi, Maria Chiara, Boot, Jesca, Crosbie, Nicola, Visco, Carlo, Arcaini, Luca, Chaganti, Sridhar, Alencar, Alvaro J., Armiento, Daniele, Romano, Ilaria, Sassone, Marianna C., Dietrich, Jorg, Itchaki, Gilad, Bruna, Riccardo, Fracchiolla, Nicola S, Arletti, Laura, Venditti, Adriano, Booth, Stephen, Musto, Pellegrino, Hoang-Xuan, Khe, Batchelor, Tracy, Cwynarski, Kate, Ferreri, Andrés J.M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Hematology. Published by Elsevier Inc. 2022
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665276/ http://dx.doi.org/10.1182/blood-2022-167915

Ejemplares similares

Impact of severe acute respiratory syndrome coronavirus‐2 infection on the outcome of primary central nervous system lymphoma treatment: A study of the International PCNSL Collaborative Group
por: Steffanoni, Sara, et al.
Publicado: (2022)

How we treat primary central nervous system lymphoma
por: Calimeri, T., et al.
Publicado: (2021)

Diagnosis and Treatment Using Autologous Stem-Cell Transplantation in Primary Central Nervous System Lymphoma: A Systematic Review
por: Steffanoni, Sara, et al.
Publicado: (2023)

Treatment outcome and prognostic factors in PCNSL
por: Niparuck, Pimjai, et al.
Publicado: (2019)

Optimizing MATRix as remission induction in PCNSL: de-escalated induction treatment in newly diagnosed primary CNS lymphoma
por: Wendler, Julia, et al.
Publicado: (2022)

CLRM-15 TRIAL IN PROGRESS: A PHASE 1B/2 STUDY OF GB5121, A NOVEL, HIGHLY SELECTIVE, POTENT, AND CNS-PENETRANT INHIBITOR OF BRUTON’S TYROSINE KINASE (BTKI) FOR RELAPSED/REFRACTORY PRIMARY/SECONDARY CNS LYMPHOMA (R/R PCNSL/SCNSL) AND PRIMARY VITREORETINAL LYMPHOMA (PVRL)
por: Soussain, Carole, et al.
Publicado: (2022)

ML-11 Tirabrutinib treatment for recurrent or refractory PCNSL
por: Ohka, Fumiharu, et al.
Publicado: (2021)

Radiomics-Based Machine Learning Model for Predicting Overall and Progression-Free Survival in Rare Cancer: A Case Study for Primary CNS Lymphoma Patients
por: Destito, Michela, et al.
Publicado: (2023)

Different imaging patterns of PCNSL and IVL: a case report
por: Jeon, Seung-Ho, et al.
Publicado: (2019)

Liquid Biopsy and Other Non-Invasive Diagnostic Measures in PCNSL
por: Baraniskin, Alexander, et al.
Publicado: (2021)

GSEA-assisted gene signatures valid for combinations of prognostic markers in PCNSL
por: Takashima, Yasuo, et al.
Publicado: (2020)

New genetic prognostic biomarkers in primary central nervous system lymphoma (PCNSL)
por: Gomes Candido Reis, Diego, et al.
Publicado: (2021)

ML-17 Clinical usefulness of Tirabrutinib in recurrent PCNSL: single institute experience
por: Matsuura, Jin, et al.
Publicado: (2021)

ML-13 AN ATTEMPT OF RECHALLENGE OF HD-MTX AND MAINTENANCE THERAPY OF MTX FOR PATIENTS WITH PCNSL
por: Yamaguchi, Takashi, et al.
Publicado: (2019)

ML-5 THE TRANSITION OF THE TREATMENT OF 60 PCNSL CASES AT OUR INSTITUTION AND CLINICAL CONSIDERATIONS
por: Yoshitake, Hidenobu, et al.
Publicado: (2022)

ML-4 POLICY CHANGE TO PCNSL TREATMENT LED BY HEMATOLOGY, AND INITIAL TREATMENT RESULTS
por: Hashiba, Tetsuo, et al.
Publicado: (2022)

Usefulness of Serum Soluble Interleukin-2 Receptor Levels for Differentiating between PCNSL and SCNSL
por: MITOBE, Yuta, et al.
Publicado: (2023)

Deep learning-based overall survival prediction model in patients with rare cancer: a case study for primary central nervous system lymphoma
por: She, Ziyu, et al.
Publicado: (2023)

International multicenter retrospective analysis of thiotepa-based autologous stem cell transplantation for secondary central nervous system lymphoma
por: Khwaja, Jahanzaib, et al.
Publicado: (2022)

Infection par le SARS-CoV 2 chez les patients avec lymphome cérébral primitif du système nerveux central : étude préliminaire de la sévérité et des facteurs pronostics
por: Laurenge, Alice, et al.
Publicado: (2021)

ML-15 The future direction of treatment development for primary central nervous system lymphoma (PCNSL)
por: Shinojima, Naoki, et al.
Publicado: (2020)

ML-13 The primary treatment outcomes and future problems of PCNSL elderly patients in our institute
por: Kambe, Atsushi, et al.
Publicado: (2020)

ML-14 Re-challenge and maintenance therapy of methotrexate for elderly PCNSL patients with low scored KPS
por: Yamaguchi, Takashi, et al.
Publicado: (2020)

ML-12 Clinical impact and management of skin-related disorders during treatment of relapsed PCNSL by tirabrutinib
por: Sasaki, Nobuyoshi, et al.
Publicado: (2021)

Expression and Clinical Significance of Th1/Th2/Th17 Cytokines and Lymphocyte Subsets in PCNSL
por: Bian, Haiyan, et al.
Publicado: (2022)

PB2356: OUTCOMES OF PATIENTS WITH PRIMARY CNS LYMPHOMA (PCNSL) WHO UNDERWENT TREATMENT WITH DEANGELIS, MATRIX, AND PRIMAIN PROTOCOL.: A RETROSPECTIVE SINGLE-CENTER STUDY
por: Richardson, Michelle, et al.
Publicado: (2023)

Prevention and management of secondary central nervous system lymphoma
por: Bobillo, Sabela, et al.
Publicado: (2022)

Radiotherapy for newly diagnosed primary central nervous system lymphoma: role and perspective
por: Thomas, Alice, et al.
Publicado: (2023)

Methylated markers accurately distinguish primary central nervous system lymphomas (PCNSL) from other CNS tumors
por: Downs, Bradley M., et al.
Publicado: (2021)

Primary central nervous system lymphoma (PCNSL) mimicking a falx meningioma with increasingly massive intracerebral hemorrhage
por: Tomita, Yusuke, et al.
Publicado: (2023)

High-throughput quantitation of amino acids and acylcarnitine in cerebrospinal fluid: identification of PCNSL biomarkers and potential metabolic messengers
por: Ma, Jingjing, et al.
Publicado: (2023)

Targeting the Blood–Brain Tumor Barrier with Tumor Necrosis Factor-α
por: Corti, Angelo, et al.
Publicado: (2022)

Antiviral therapy of hepatitis C as curative treatment of indolent B-cell lymphoma
por: Merli, Michele, et al.
Publicado: (2016)

Improving the Classification of PCNSL and Brain Metastases by Developing a Machine Learning Model Based on (18)F-FDG PET
por: Cui, Can, et al.
Publicado: (2023)

Logics in artificial intelligence: 16th European conference, JELIA 2019, Rende, Italy, May 7-11, 2019, proceedings
por: Calimeri, Francesco, et al.
Publicado: (2019)

Role of Positron Emission Tomography in Primary Central Nervous System Lymphoma
por: Rozenblum, Laura, et al.
Publicado: (2022)

Primary Central Nervous System Lymphoma (PCNSL): Analysis of Treatment by Gamma Knife Radiosurgery and Chemotherapy in a Prospective, Observational Study
por: Alvarez-Pinzon, Andres M, et al.
Publicado: (2016)

RNU6-1 in circulating exosomes differentiates GBM from non-neoplastic brain lesions and PCNSL but not from brain metastases
por: Puigdelloses, Montserrat, et al.
Publicado: (2020)

ML-07 High expression of PD-L1 on tumor-associated macrophage is a predictive factor for favorable prognosis in PCNSL
por: Furuse, Motomasa, et al.
Publicado: (2020)

Diagnostic value of EBV-DNA in CSF for PCNSL in AIDS patients with focal brain lesions: A meta-analysis of diagnostic test
por: Ding, Xinghuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fo72mvu4cm8i19prb1j55qgj9n